Curated News
By: NewsRamp Editorial Staff
April 13, 2026
Catalyst Crew Assigns AI Healthcare Patents to Venezuelan Subsidiary
TLDR
- Catalyst Crew Technologies gains strategic advantage by assigning CardioAI, PulmoAI, and NeuroAI patents to its Venezuelan subsidiary, enhancing flexibility for regional partnerships and expansion.
- Catalyst Crew Technologies transferred three AI healthcare patents from its CEO to subsidiary Inversiones Long 33, aligning IP with operations to support development and commercialization.
- Catalyst Crew's AI healthcare technologies aim to improve medical access and efficiency in emerging markets through telehealth and predictive analytics for better patient outcomes.
- Catalyst Crew Technologies now holds CardioAI, PulmoAI, and NeuroAI patents in Venezuela, using AI to transform healthcare analytics and decision support globally.
Impact - Why it Matters
This development matters because it represents a strategic move by a healthcare technology company to better position itself in emerging markets, particularly Latin America, where access to advanced medical technology is often limited. By consolidating intellectual property in its Venezuelan subsidiary, Catalyst Crew Technologies is creating a more efficient structure for developing and commercializing AI-driven healthcare solutions like CardioAI, PulmoAI, and NeuroAI. This could potentially accelerate the deployment of telehealth infrastructure, remote patient monitoring, and clinical decision-support systems in regions that desperately need improved healthcare access and efficiency. For patients in these markets, this could mean better diagnostic capabilities, more personalized treatment plans, and reduced healthcare disparities. For the healthcare industry, it demonstrates how companies are strategically organizing their assets to navigate complex international regulatory environments while bringing innovative technologies to underserved populations.
Summary
Catalyst Crew Technologies Corp. (OTC: CCTC), a digital health and artificial intelligence technology company focused on emerging markets, has announced a significant strategic move by assigning key intellectual property assets to its wholly-owned Venezuelan operating subsidiary, Inversiones Long 33, C.A. The intellectual property, previously held by CEO Dr. Kevin Rodan Levy, consists of three Venezuelan patents covering proprietary technologies called CardioAI, PulmoAI, and NeuroAI. These AI-driven healthcare technologies are designed to support data-driven healthcare analytics, predictive modeling, and clinical decision-support applications, positioning the company to better serve the Latin American region through its digital health platform.
This assignment represents a crucial step in aligning the company's intellectual property with its operational structure, allowing the Venezuelan subsidiary to serve as the primary development and commercialization vehicle for the technology platform in the region. According to the company, consolidating intellectual property at the operating level enhances strategic flexibility, supports regulatory alignment, and may facilitate future partnerships, licensing opportunities, and regional expansion initiatives. Dr. Kevin Rodan Levy emphasized that establishing a clear foundation around core technologies enables the company to move forward with development, partnerships, and broader intellectual property protection strategies across additional markets, as detailed in the original release on www.newmediawire.com.
The company continues to advance its digital health and AI platform with a focus on scalable healthcare solutions including telehealth infrastructure, remote patient monitoring, and advanced healthcare analytics designed to improve access, efficiency, and care coordination in emerging markets. Catalyst Crew Technologies Corp. is actively executing its strategic transition into AI-enabled healthcare and pursuing opportunities across Latin America, building an integrated healthcare technology platform positioned to address the growing demand for modernized healthcare delivery systems. For more information, investors can visit https://catalystcrewai.com or review the company's filings with the U.S. Securities and Exchange Commission at www.sec.gov, as the company maintains transparency through proper regulatory channels.
Source Statement
This curated news summary relied on content disributed by NewMediaWire. Read the original source here, Catalyst Crew Assigns AI Healthcare Patents to Venezuelan Subsidiary
